These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 1758464)

  • 21. Clozapine for the treatment of levodopa-induced psychosis in Parkinson's disease.
    Rosenthal SH; Fenton ML; Harnett DS
    Gen Hosp Psychiatry; 1992 Jul; 14(4):285-6. PubMed ID: 1505751
    [No Abstract]   [Full Text] [Related]  

  • 22. Severe gastrointestinal complications in patients with levodopa/carbidopa intestinal gel infusion.
    Klostermann F; Jugel C; Bömelburg M; Marzinzik F; Ebersbach G; Müller T
    Mov Disord; 2012 Nov; 27(13):1704-5. PubMed ID: 23192929
    [No Abstract]   [Full Text] [Related]  

  • 23. [Chronic inflammatory demyelinating polyradiculoneuropathy associated with treatment using intraduodenal infusion of levodopa-carbidopa].
    Rivero-de-Aguilar A; Sesar A; Fernandez-Pajarin G; Ares-Pensado B; Castro A
    Rev Neurol; 2019 Oct; 69(7):304-306. PubMed ID: 31559631
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Parkinson disease treatment in hospitals and nursing facilities: avoiding pitfalls.
    Ahlskog JE
    Mayo Clin Proc; 2014 Jul; 89(7):997-1003. PubMed ID: 24996235
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Skin rash associated with Sinemet does not equal levodopa allergy.
    Chou KL; Stacy MA
    Neurology; 2007 Mar; 68(13):1078-9. PubMed ID: 17389317
    [No Abstract]   [Full Text] [Related]  

  • 26. Hemiballism and chorea in a patient with parkinsonism due to a multisystem degeneration.
    Steiger MJ; Pires M; Scaravilli F; Quinn NP; Marsden CD
    Mov Disord; 1992; 7(1):71-7. PubMed ID: 1557069
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Time course of loss of clinical benefit following withdrawal of levodopa/carbidopa and bromocriptine in early Parkinson' s disease.
    Hauser RA; Koller WC; Hubble JP; Malapira T; Busenbark K; Olanow CW
    Mov Disord; 2000 May; 15(3):485-9. PubMed ID: 10830413
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Duodenal levodopa infusion monotherapy vs oral polypharmacy in advanced Parkinson disease.
    Nyholm D; Nilsson Remahl AI; Dizdar N; Constantinescu R; Holmberg B; Jansson R; Aquilonius SM; Askmark H
    Neurology; 2005 Jan; 64(2):216-23. PubMed ID: 15668416
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of Parkinson's disease with controlled-release Carbidopa/L-DOPA.
    Pahwa R; Koller WC
    Adv Neurol; 1996; 69():487-91. PubMed ID: 8615169
    [No Abstract]   [Full Text] [Related]  

  • 30. Levodopa in pregnancy.
    Nomoto M; Kaseda S; Iwata S; Osame M; Fukuda T
    Mov Disord; 1997 Mar; 12(2):261. PubMed ID: 9087994
    [No Abstract]   [Full Text] [Related]  

  • 31. Parkinson's disease: recent advances in therapy.
    Jankovic J
    South Med J; 1988 Aug; 81(8):1021-7. PubMed ID: 3043683
    [No Abstract]   [Full Text] [Related]  

  • 32. Treatment of Parkinson's disease.
    Lieberman A
    Curr Opin Neurol Neurosurg; 1993 Jun; 6(3):339-43. PubMed ID: 8507903
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The use of stalevo in the treatment of patients with Parkinson's disease].
    Kretova AS; Lyubimov AV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(10):35-8. PubMed ID: 25591514
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sinemet CR in Parkinson's disease.
    Pfeiffer RF; Wilken KE; Glaeske CS; Hofman R
    Nebr Med J; 1991 Jan; 76(1):8-10. PubMed ID: 1997878
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Drug therapy of Parkinson's disease].
    Zhou XD
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1985 Aug; 18(4):193-6. PubMed ID: 4075905
    [No Abstract]   [Full Text] [Related]  

  • 36. Guillain-Barre/CIDP-like neuropathy in two parkinsonian patients following intestinal levodopa/carbidopa treatment.
    Galazky I; Schoof J; Stallforth S; Kupsch A; Heinze HJ; Kluge C
    Parkinsonism Relat Disord; 2014 Jan; 20(1):125-7. PubMed ID: 24044946
    [No Abstract]   [Full Text] [Related]  

  • 37. First emergence of "delayed-on" and "dose failure" phenomena in a patient with Parkinson's disease following vagotomy.
    Djaldetti R; Achiron A; Ziv I; Melamed E
    Mov Disord; 1994 Sep; 9(5):582-3. PubMed ID: 7990855
    [No Abstract]   [Full Text] [Related]  

  • 38. Adductor laryngeal breathing dystonia in a patient with lubag (X-linked dystonia-Parkinsonism syndrome).
    Lew MF; Shindo M; Moskowitz CB; Wilhelmsen KC; Fahn S; Waters CH
    Mov Disord; 1994 May; 9(3):318-20. PubMed ID: 8041372
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Levodopa + carbidopa + entacapone. Entacapone: a second look: new preparations. Parkinson's disease: a modest effect.
    Prescrire Int; 2005 Apr; 14(76):51-4. PubMed ID: 15875340
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Amantadine and a fixed combination of carbidopa and levodopa in parkinsonism: a preliminary report.
    Savery F
    Curr Ther Res Clin Exp; 1976 Mar; 19(3):337-8. PubMed ID: 817863
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.